45 related articles for article (PubMed ID: 22446635)
1. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.
Landrum ML; Huppler Hullsiek K; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; Peel S; Agan BK
Vaccine; 2009 Jul; 27(34):4731-8. PubMed ID: 19540026
[TBL] [Abstract][Full Text] [Related]
2. Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.
Mizusawa M; Perlman DC; Lucido D; Salomon N
Int J STD AIDS; 2014 Mar; 25(3):201-6. PubMed ID: 24216032
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
Landrum ML; Hullsiek KH; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; O'Connell RJ; Fieberg A; Chun HM; Marconi VC; Dolan MJ; Agan BK;
AIDS; 2010 Feb; 24(4):545-55. PubMed ID: 19487908
[TBL] [Abstract][Full Text] [Related]
4. Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections.
Khanal S; Tang Q; Cao D; Zhao J; Nguyen LN; Oyedeji OS; Dang X; Nguyen LNT; Schank M; Thakuri BKC; Ogbu C; Morrison ZD; Wu XY; Zhang Z; He Q; El Gazzar M; Li Z; Ning S; Wang L; Moorman JP; Yao ZQ
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907975
[TBL] [Abstract][Full Text] [Related]
5. ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy.
Zhao J; Nguyen LNT; Nguyen LN; Dang X; Cao D; Khanal S; Schank M; Thakuri BKC; Ogbu SC; Morrison ZD; Wu XY; Li Z; Zou Y; El Gazzar M; Ning S; Wang L; Moorman JP; Yao ZQ
Front Immunol; 2019; 10():2531. PubMed ID: 31781094
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.
Couto E; Diaz-Brito V; Mothe B; Guardo AC; Fernandez I; Ugarte A; Etcheverry F; Gómez CE; Esteban M; Pich J; Arnaiz JA; López Bernaldo de Quirós JC; Brander C; Plana M; García F; Leal L
Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31703287
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.
Farooq PD; Sherman KE
Curr HIV/AIDS Rep; 2019 Oct; 16(5):395-403. PubMed ID: 31468298
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus vaccination in HIV-infected people: A review.
Catherine FX; Piroth L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28267387
[TBL] [Abstract][Full Text] [Related]
9. Immunization of HIV-infected adult patients - French recommendations.
Frésard A; Gagneux-Brunon A; Lucht F; Botelho-Nevers E; Launay O
Hum Vaccin Immunother; 2016 Nov; 12(11):2729-2741. PubMed ID: 27409293
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies.
Özkurt ZN; Suyanı E; Haznedar R; Yağcı M
Turk J Haematol; 2016 Sep; 33(3):231-5. PubMed ID: 27094506
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and A vaccination in HIV-infected adults: A review.
Mena G; García-Basteiro AL; Bayas JM
Hum Vaccin Immunother; 2015; 11(11):2582-98. PubMed ID: 26208678
[TBL] [Abstract][Full Text] [Related]
12. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil.
Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
Braz J Infect Dis; 2015; 19(2):181-6. PubMed ID: 25626960
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
15. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
16. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
van den Berg R; van Hoogstraten I; van Agtmael M
AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
[TBL] [Abstract][Full Text] [Related]
17. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
Ni JD; Xiong YZ; Wang XJ; Xiu LC
Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
[TBL] [Abstract][Full Text] [Related]
18. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
